- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 9, 2025 | 9.86M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $15.06M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $18.68M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $19.67M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $22.17M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $50.34M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $54.85M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $30.59M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $69.44M |
| Total Assets | Q2 2025 · Mar 31, 2024 | $64.2M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 9.46M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 9.37M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $0 |
| Capex | Q2 2025 · Mar 31, 2024 | $134K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $3.32M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $48.25M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $46.47M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $46.15M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.16 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.15 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.16 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.16 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $4.52M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $8.26M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $726K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $1.43M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.59M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.52M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $1.23M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $891K |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $6.48M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $10.57M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $7.23M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $18.51M |